Search Results

There are 137630 results for: content related to: Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion

  1. Effects of Glucocorticoids on Mood, Memory, and the Hippocampus

    Annals of the New York Academy of Sciences

    Volume 1179, Issue 1, October 2009, Pages: 41–55, E. Sherwood Brown

    Version of Record online : 3 NOV 2009, DOI: 10.1111/j.1749-6632.2009.04981.x

  2. You have free access to this content
    Psychiatric complications of treatment with corticosteroids: Review with case report

    Psychiatry and Clinical Neurosciences

    Volume 65, Issue 6, October 2011, Pages: 549–560, Heather A. Kenna, Amy W. Poon, C. Paula de los Angeles and Lorrin M. Koran

    Version of Record online : 17 OCT 2011, DOI: 10.1111/j.1440-1819.2011.02260.x

  3. Corticosteroid-induced hyperglycemia is increased 10-fold in patients with pemphigus

    International Journal of Dermatology

    Volume 51, Issue 10, October 2012, Pages: 1248–1252, Afsaneh Alavi, Julia Lowe, Scott Walsh, David Juurlink, Soroush Mortaz-Hedjri and Neil H. Shear

    Version of Record online : 20 SEP 2012, DOI: 10.1111/j.1365-4632.2012.05470.x

  4. Is enough attention being given to the adverse effects of corticosteroid therapy?

    Journal of Clinical Pharmacy and Therapeutics

    Volume 25, Issue 3, June 2000, Pages: 227–234, Hougardy, Peterson, Bleasel and Randall

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2710.2000.00284.x

  5. Doctors’ beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention

    Journal of Clinical Pharmacy and Therapeutics

    Volume 36, Issue 3, June 2011, Pages: 356–366, M. Duyvendak, M. Naunton, E. N. van Roon and J. R. B. J Brouwers

    Version of Record online : 19 OCT 2010, DOI: 10.1111/j.1365-2710.2010.01185.x

  6. You have free access to this content
    Meta-analysis: ertapenem for complicated intra-abdominal infections

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 10, May 2008, Pages: 919–931, M. E. FALAGAS, G. PEPPAS, G. C. MAKRIS, D. E. KARAGEORGOPOULOS and D. K. MATTHAIOU

    Version of Record online : 9 FEB 2008, DOI: 10.1111/j.1365-2036.2008.03642.x

  7. You have free access to this content
    Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

    Arthritis & Rheumatism

    Volume 42, Issue 11, November 1999, Pages: 2309–2318, Stanley Cohen, Robert M. Levy, Michael Keller, Eugene Boling, Ronald D. Emkey, Maria Greenwald, Thomas M. Zizic, Stanley Wallach, Kathryn L. Sewell, Barbara P. Lukert, Douglas W. Axelrod and Arkadi A. Chines

    Version of Record online : 26 APR 2001, DOI: 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K

  8. Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy

    British Journal of Dermatology

    Volume 163, Issue 4, October 2010, Pages: 832–837, C. Arena, A.-S. Morin, T. Blanchon, T. Hanslik, J. Cabane, A. Dupuy and L. Fardet

    Version of Record online : 28 MAY 2010, DOI: 10.1111/j.1365-2133.2010.09877.x

  9. You have free access to this content
    Corticosteroid-induced psychosis in rheumatoid arthritis

    Progress in Neurology and Psychiatry

    Volume 20, Issue 5, September/October 2016, Pages: 13–15, Louisa Ward and Joji George

    Version of Record online : 25 OCT 2016, DOI: 10.1002/pnp.441

  10. You have free access to this content
    Prevention and treatment of systemic glucocorticoid side effects

    International Journal of Dermatology

    Volume 49, Issue 3, March 2010, Pages: 239–248, Siamak Moghadam-Kia and Victoria P. Werth

    Version of Record online : 19 FEB 2010, DOI: 10.1111/j.1365-4632.2009.04322.x

  11. Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

    International Journal of Dermatology

    Volume 50, Issue 2, February 2011, Pages: 129–146, Yevgeniy Balagula, Claus Garbe, Patricia L. Myskowski, Axel Hauschild, Bernardo L. Rapoport, Christine B. Boers-Doets and Mario E. Lacouture

    Version of Record online : 19 JAN 2011, DOI: 10.1111/j.1365-4632.2010.04791.x

  12. THE CHANGES AND DIFFICULTIES EXPERIENCED BY PATIENTS USING STEROIDS

    Journal of Renal Care

    Volume 36, Issue 2, June 2010, Pages: 81–89, Guler Balcı Alparslan and Sevgi Sun Kapucu

    Version of Record online : 19 MAY 2010, DOI: 10.1111/j.1755-6686.2010.00143.x

  13. Corticosteroid-Mediated Immunoregulation in Man

    Immunological Reviews

    Volume 65, Issue 1, August 1982, Pages: 133–155, Thomas R. Cupps and Anthony S. Fauci

    Version of Record online : 28 APR 2006, DOI: 10.1111/j.1600-065X.1982.tb00431.x

  14. The pathogenetic role of rod-shaped bacteria containing intracellular granules in the vellus hairs of a patient with perioral dermatitis: A comparison with perioral corticosteroid-induced rosacea

    Australasian Journal of Dermatology

    Volume 57, Issue 3, August 2016, Pages: 225–228, Azusa Maeda, Naoko Ishiguro and Makoto Kawashima

    Version of Record online : 20 APR 2015, DOI: 10.1111/ajd.12344

  15. Reproductive Endocrinology and Clinical Aspects of Obesity in Women

    Annals of the New York Academy of Sciences

    Volume 1127, Issue 1, April 2008, Pages: 140–146, Mostafa Metwally, William L. Ledger and Tin Chiu Li

    Version of Record online : 17 APR 2008, DOI: 10.1196/annals.1434.000

  16. Does alternate-day cloprednol therapy prevent bone loss? A longitudinal double-blind, controlled clinical study

    Clinical Pharmacology & Therapeutics

    Volume 48, Issue 4, October 1990, Pages: 455–466, Tullio C Medici and Peter Rüegsegger

    Version of Record online : 16 OCT 1990, DOI: 10.1038/clpt.1990.175

  17. Preliminary study of etidronate for prevention of corticosteroid-induced osteoporosis caused by oral glucocorticoid therapy

    Clinical and Experimental Dermatology

    Volume 36, Issue 2, March 2011, Pages: 165–168, F. Furukawa, C. Kaminaka, T. Ikeda, N. Kanazawa, Y. Yamamoto, C. Ohta, T. Nishide, K. Tsujioka, M. Hattori, K. Uede, M. Hata and the Wakayama Study Group on Dermatological Use of Bisphosphonates

    Version of Record online : 20 MAY 2010, DOI: 10.1111/j.1365-2230.2010.03856.x

  18. Corticosteroid-associated avascular necrosis: dose relationships and early diagnosis

    Annals of the New York Academy of Sciences

    Volume 1240, Issue 1, December 2011, Pages: 38–46, Roy K. Aaron, Anne Voisinet, Jennifer Racine, Yousaf Ali and Edward R. Feller

    Version of Record online : 15 DEC 2011, DOI: 10.1111/j.1749-6632.2011.06218.x

  19. Fructose consumption: recent results and their potential implications

    Annals of the New York Academy of Sciences

    Volume 1190, Issue 1, March 2010, Pages: 15–24, Kimber L. Stanhope and Peter J. Havel

    Version of Record online : 16 MAR 2010, DOI: 10.1111/j.1749-6632.2009.05266.x

  20. Cutaneous alternariosis in a cardiac transplant recipient

    Australasian Journal of Dermatology

    Volume 42, Issue 1, February 2001, Pages: 46–49, Tanya K Gilmour, Ed Rytina, P Brian O’Connell and Jane C. Sterling

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1440-0960.2001.00473.x